Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2021 07:00 ET | Source: Passage Bio

Passage Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights

- On track to initiate three Phase 1/2 clinical programs in the first half of 2021: PBGM01 for GM1 gangliosidosis (GM1), PBFT02 for frontotemporal dementia with granulin mutations, and PBKR03 for...
March 02, 2021 16:01 ET | Source: Passage Bio

Passage Bio to Participate in Upcoming March Investor Conferences

PHILADELPHIA, March 02, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous...
February 24, 2021 07:00 ET | Source: Passage Bio

Passage Bio to Report Fourth Quarter and Full-Year 2020 Financial Results on March 3, 2021

PHILADELPHIA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous...
February 20, 2021 17:27 ET | Source: Christopher C. Lee Photography & Film

San Francisco Studio Christopher C. Lee Photography & Film Accepted Into Top Worldwide Photography Hall of Fame

San Francisco, Feb. 20, 2021 (GLOBE NEWSWIRE) -- Seeing the world with a total paradigm shift can be achieved through the camera lens. To view our immediate reality in its full beauty, striking...
February 19, 2021 07:00 ET | Source: Passage Bio

Passage Bio Appoints Maxine Gowen, Ph.D. to Board of Directors

PHILADELPHIA, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous...
February 17, 2021 09:00 ET | Source: EagleView Technologies

EagleView Measurements Help Solar Installers Capture the Sun for American Homes

BELLEVUE, Wash., Feb. 17, 2021 (GLOBE NEWSWIRE) -- EagleView, a leading technology provider of aerial imagery, data analytics and GIS solutions, and the industry leader in image clarity and rooftop...
February 08, 2021 07:00 ET | Source: Passage Bio

FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of Patients with Early Infantile Krabbe Disease, A Rare Pediatric Disorder with No Approved Disease-Modifying Treatment Options

- Phase 1/2 trial expected to commence in first half of 2021 - Company has three INDs cleared for rare monogenic CNS disorders PHILADELPHIA, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc....
January 31, 2021 12:42 ET | Source: 2021.Reviews

Language of Desire Brings Sparks To Relationships? - The Language of Desire with Felicity Keith Reviews by 2021.reviews

New York City, NY, Jan. 31, 2021 (GLOBE NEWSWIRE) -- Language of Desire is an online, digital guidebook that aims to educate women of men's most profound intimate desires. We can always agree that...
January 28, 2021 08:00 ET | Source: Valley National Bank

Valley National Bancorp Reports Strong Fourth Quarter Net Income Driven by a 21 Percent Increase in Net Interest Income

NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, today reported net income for the fourth quarter 2020 of $105.4...
January 28, 2021 07:00 ET | Source: Passage Bio

Passage Bio Receives FDA Clearance of IND Application for PBFT02 Gene Therapy Candidate for Treatment of Patients with Frontotemporal Dementia with Granulin Mutations

– Second Product Candidate Expected to Enter Clinic in First Half of 2021 – Preclinical Data Underscore Treatment Potential for PBFT02 in Frontotemporal Dementia with Granulin (GRN) Mutations, a...